Dosage Compensation in Females with X-Linked Metabolic Disorders
Through the use of new genomic and metabolomic technologies, our comprehension of the molecular and biochemical etiologies of genetic disorders is rapidly expanding, and so are insights into their varying phenotypes. Dosage compensation (lyonization) is an epigenetic mechanism that balances the expr...
Main Authors: | Patrycja Juchniewicz, Ewa Piotrowska, Anna Kloska, Magdalena Podlacha, Jagoda Mantej, Grzegorz Węgrzyn, Stefan Tukaj, Joanna Jakóbkiewicz-Banecka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4514 |
Similar Items
-
Case Report: De novo DDX3X mutation caused intellectual disability in a female with skewed X-chromosome inactivation on the mutant allele
by: Yixi Sun, et al.
Published: (2022-10-01) -
Allelic and dosage effects of NHS in X-linked cataract and Nance–Horan syndrome: a family study and literature review
by: Caroline Miller, et al.
Published: (2021-10-01) -
Sex-specific differences in primary Sjögren's disease
by: Achamaporn Punnanitinont, et al.
Published: (2023-05-01) -
Editorial: Gene Regulation From the X-Chromosome During Development and Disease
by: Montserrat C. Anguera, et al.
Published: (2020-04-01) -
Heterozygous Deletion of the SHOX Gene Enhancer in two Females With Clinical Heterogeneity Associating With Skewed XCI and Escaping XCI
by: Yixi Sun, et al.
Published: (2019-11-01)